GABAPENTIN
- Product NDC
- 69097-813
- 11-digit product format
- 690970813
- Labeler code
- 69097
- Product ID
- 69097-813_fdeea2da-e306-45d8-a27a-e8be090319ea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Cipla USA Inc.
- Application
- ANDA090705
- Marketing category
- ANDA
- Marketing start
- 2016-06-29
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GABAPENTIN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GABAPENTIN | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6CW7F3G59X |
| Rxcui | 310430, 310431, 310432 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69097-813-07 | GABAPENTIN | 100 in 1 BOTTLE | CAPSULE | 100 | | 8 |
| 69097-813-12 | GABAPENTIN | 500 in 1 BOTTLE | CAPSULE | 500 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-813 | GABAPENTIN CAPSULE [CIPLA USA INC.] | 7 | Current NDC, Legacy NDC, 2 package rows | 20241115_9e4eca9c-6a2c-4ede-a252-1a27094bf594.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-813-07 | 69097081307 | 100 CAPSULE in 1 BOTTLE (69097-813-07) | 100 capsule | 2016-06-29 | 0000-00-00 | No | No | Current |
| 69097-813-12 | 69097081312 | 500 CAPSULE in 1 BOTTLE (69097-813-12) | 500 capsule | 2016-06-29 | 0000-00-00 | No | No | Current |